MUMBAI, Nov. 16 -- Transasia Bio-Medicals is exploring a sale of up to 20% stake to raise $150-200 million, drawing interest from several large private equity funds, as the medical equipment maker considers its first external capital raise, three people familiar with the matter said.

Funds including TPG, Warburg Pincus, ChrysCapital, Motilal Oswal and Quadria Capital have expressed interest in the company, the people said, adding that discussions are at an early stage. All three spoke on condition of anonymity as the discussions are private.

"The round is likely a mix of primary and secondary share sale although the exact structures are subject to change depending on the incoming investor. O3 Capital is helping the company with the fund...